|4May 2, 7:39 PM ET

BIZZARI JEAN-PIERRE 4

4 · HALOZYME THERAPEUTICS INC · Filed May 2, 2018

Insider Transaction Report

Form 4
Period: 2018-05-02
Transactions
  • Award

    Common Stock

    2018-05-02+10,36361,312 total
Footnotes (1)
  • [F1]Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 2, 2019 and (ii) the date of the Issuer's next annual meeting of stockholders.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -